{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:19:42Z","timestamp":1791051582791,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":3342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1093\/annonc\/mdq067","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T16:09:22Z","timestamp":1269533362000},"page":"2023-2028","source":"Crossref","is-referenced-by-count":99,"title":["The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials"],"prefix":"10.1016","volume":"21","author":[{"given":"P.","family":"Wheatley-Price","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Blackhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.-M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jitlal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hackshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Booton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Danson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lorigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Thatcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.A.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdq067_bb0010","author":"Cancer Research UK","year":"2006","journal-title":"UK Lung Cancer and Smoking Statistics"},{"key":"10.1093\/annonc\/mdq067_bb0015","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1023\/B:CACO.0000036176.33007.17","article-title":"Lung cancer incidence trends in black and white young adults by gender (United States)","volume":"15","author":"Polednak","year":"2004","journal-title":"Cancer Causes Control"},{"key":"10.1093\/annonc\/mdq067_bb0020","first-page":"26","article-title":"The influence of sex on efficacy, toxicity and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) non-small cell lung cancer (NSCLC) chemotherapy trials","author":"Wheatley-Price","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.lungcan.2004.08.014","article-title":"The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years","volume":"47","author":"Batevik","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdq067_bb0030","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1200\/JCO.2006.08.1455","article-title":"Sex differences in lung cancer survival: do tumors behave differently in elderly women?","volume":"25","author":"Wisnivesky","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0035","first-page":"25","article-title":"Toxicity and survival by sex in patients with advanced non-small cell lung carcinoma (NSCLC) on modern Southwest Oncology Group (SWOG) trials","author":"Albain","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0040","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/annonc\/mdl183","article-title":"Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975","volume":"17","author":"Efficace","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0045","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01243894-200606000-00011","article-title":"Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594","volume":"1","author":"Wakelee","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.athoracsur.2003.11.021","article-title":"Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002","volume":"78","author":"Visbal","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1093\/annonc\/mdq067_bb0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0169-5002(02)00103-4","article-title":"The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer","volume":"37","author":"Keller","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdq067_bb0060","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/annonc\/mdl078","volume":"17","author":"Booton","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0065","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/cncr.11535","article-title":"Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma","volume":"98","author":"Danson","year":"2003","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdq067_bb0070","article-title":"A phase III randomised, double blind, placebo controlled trial of gemcitabine\/carboplatin with or without thalidomide in advanced non-small cell lung cancer (NSCLC): C1-03","volume":"2","author":"Lee","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0075","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1200\/JCO.2005.03.037","article-title":"Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group","volume":"23","author":"Rudd","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0080","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.JTO.0000283151.50497.ac","article-title":"A pragmatic, randomised study to compare the hospitalisation rates of two platinum-based outpatient regimens (gemicitabine\/cisplatin vs. gemcitabine\/carboplatin) in non-small cell lung cancer (NSCLC)\u2014UK Swiss collaboration","volume":"2","author":"Blackhall","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdq067_bb0090","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdq067_bb0095","first-page":"235","article-title":"Phase III study of docetaxel-cisplatin (DC) or docetaxel-carboplatin (DCb) versus vinorelbine-cisplatin (VC) as first-line treatment of advanced non-small cell lung cancer (NSCLC): analyses by gender","volume":"49S","author":"Belani","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdq067_bb0100","first-page":"23","article-title":"A pooled analysis of 11 NCCTG advanced stage non-small cell lung cancer (NSCLC) trials reveals the importance of baseline blood counts on clinical outcomes","author":"Mandrekar","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1550-8579(04)80009-3","article-title":"Is there a gender difference in non-small cell lung cancer survival?","volume":"1","author":"Chatkin","year":"2004","journal-title":"Gend Med"},{"key":"10.1093\/annonc\/mdq067_bb0110","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1200\/JCO.1990.8.8.1402","article-title":"Sex-associated differences in presentation and survival in patients with lung cancer","volume":"8","author":"Ferguson","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JTO.0b013e31815e8577","article-title":"A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers","volume":"3","author":"Asamura","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/021849230401200214","article-title":"Impact of size, histology, and gender on stage IA non-small cell lung cancer","volume":"12","author":"Campione","year":"2004","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1093\/annonc\/mdq067_bb0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/02841860310017973","article-title":"Sex differences in survival in non-small cell lung cancer patients 1974\u20131998","volume":"43","author":"Moore","year":"2004","journal-title":"Acta Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0130","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2119::AID-CNCR12>3.0.CO;2-1","article-title":"Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients","volume":"78","author":"Palomares","year":"1996","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdq067_bb0135","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/1097-0142(19940215)73:4<1163::AID-CNCR2820730407>3.0.CO;2-J","article-title":"Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features","volume":"73","author":"Barsky","year":"1994","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdq067_bb0140","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ejso.2007.01.001","article-title":"Gender differences in non-small cell lung cancer: a population-based study","volume":"33","author":"Caldarella","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00008469-200106000-00005","article-title":"Gender-specific incidence trends in lung cancer by histological type in Sweden, 1958-1996","volume":"10","author":"Li","year":"2001","journal-title":"Eur J Cancer Prev"},{"key":"10.1093\/annonc\/mdq067_bb0150","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/annonc\/mdf187","article-title":"Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases","volume":"13","author":"Radzikowska","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0155","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/jnci\/89.21.1580","article-title":"Cigarette smoking and changes in the histopathology of lung cancer","volume":"89","author":"Thun","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdq067_bb0160","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1200\/JCO.2005.04.8033","article-title":"Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity","volume":"24","author":"Toh","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0165","first-page":"26","article-title":"Epidemiology study of never-smokers with non-small cell lung cancer (NSCLC): high percentages of Asian and Hispanic female never-smokers and the significance of Asian ethnicity","author":"Ou","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0170","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1200\/JCO.2005.11.486","article-title":"Lung cancer in women","volume":"23","author":"Patel","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq067_bb0175","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.296.2.180","article-title":"Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer","volume":"296","author":"Henschke","year":"2006","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdq067_bb0180","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/oxfordjournals.aje.a116857","article-title":"Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type","volume":"138","author":"Risch","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1093\/annonc\/mdq067_bb0185","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/carcin\/17.10.2201","article-title":"p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels","volume":"17","author":"Kure","year":"1996","journal-title":"Carcinogenesis"},{"key":"10.1093\/annonc\/mdq067_bb0190","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/humu.10177","article-title":"The TP53 gene, tobacco exposure, and lung cancer","volume":"21","author":"Toyooka","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1093\/annonc\/mdq067_bb0195","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq067_bb0200","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1158\/1078-0432.CCR-07-0216","article-title":"The impact of sex and smoking status on the mutational spectrum of epidermal growth factor receptor gene in non small cell lung cancer","volume":"13","author":"Toyooka","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdq067_bb0205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1349-7006.2007.00688.x","article-title":"Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma","volume":"99","author":"Toyooka","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1093\/annonc\/mdq067_bb0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1634\/theoncologist.2008-0232","article-title":"The differential efficacy of pemetrexed according to NSCLC histology: a review of two phase III studies","volume":"14","author":"Scagliotti","year":"2009","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdq067_bb0215","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/CCO.0b013e3282f335a3","article-title":"Epidermal growth factor receptor inhibitors in the treatment of lung cancer: reality and hopes","volume":"20","author":"Wheatley-Price","year":"2008","journal-title":"Curr Opin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419395742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419395742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/10\/2023\/901460\/mdq067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:13:03Z","timestamp":1624518783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419395742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0923753419395742"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdq067","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}